Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: Post Market Clinical Follow-Up KeriFuse®

View source ↗

Summary

Post-market clinical follow-up study of KeriFuse for arthritis (NCT06546332) remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KeriFuse

Snippet

Sponsor: Keri Medical SA | Conditions: Arthritis | Status: ACTIVE_NOT_RECRUITING